CI_with has_Ingredient has_MoA has_PE may_prevent Drug Hypersensitivity [Disease/Finding] Graft vs Host Disease [Disease/Finding] basiliximab [Chemical/Ingredient] Decreased Cytokine Activity [PE] Decreased Lymphocyte Cell Production [PE] Interleukin 2 Receptor Antagonists [MoA] B [Preparations] BASILIXIMAB Ingredient 196102 basiliximab C0676831 9927MT646M N0000148568 Active <VANDF_Record>50.416^3784^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3784</VA_IEN> <VANDF_Record>50.6^3509^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3509</VA_IEN> BASILIXIMAB C11516 4021113